Is Elevai Labs, Stock a Good Investment?
Elevai Labs, Investment Advice | ELAB |
- Examine Elevai Labs,'s financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Elevai Labs,'s leadership team and their track record. Good management can help Elevai Labs, navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Elevai Labs,'s business and its evolving consumer preferences.
- Compare Elevai Labs,'s performance and market position to its competitors. Analyze how Elevai Labs, is positioned in terms of product offerings, innovation, and market share.
- Check if Elevai Labs, pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Elevai Labs,'s stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Elevai Labs, Common stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Elevai Labs, Common is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Elevai Labs, Stock
Researching Elevai Labs,'s stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book (P/B) ratio of 0.59. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elevai Labs, Common recorded a loss per share of 88.92. The entity had not issued any dividends in recent years. The firm had 1:200 split on the 27th of November 2024.
To determine if Elevai Labs, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Elevai Labs,'s research are outlined below:
| Elevai Labs, Common generated a negative expected return over the last 90 days | |
| Elevai Labs, Common has high historical volatility and very poor performance | |
| Elevai Labs, Common may become a speculative penny stock | |
| The company reported the previous year's revenue of 1.71 M. Net Loss for the year was (4.3 M) with profit before overhead, payroll, taxes, and interest of 1.74 M. | |
| Elevai Labs, generates negative cash flow from operations | |
| Elevai Labs, Common has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: PMGC Holdings Inc. Expands Investment MA Efforts, Actively Seeking Acquisitions and ... |
Elevai Labs, Quarterly Liabilities And Stockholders Equity |
|
Elevai Labs, uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Elevai Labs, Common. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Elevai Labs,'s previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Elevai Labs,'s market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.03 M.Market Cap |
|
Elevai Labs,'s profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.75) | (0.78) | |
| Return On Capital Employed | (1.08) | (1.03) | |
| Return On Assets | (0.75) | (0.78) | |
| Return On Equity | (1.29) | (1.23) |
Determining Elevai Labs,'s profitability involves analyzing its financial statements and using various financial metrics to determine if Elevai Labs, is a good buy. For example, gross profit margin measures Elevai Labs,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Elevai Labs,'s profitability and make more informed investment decisions.
Please note, the presentation of Elevai Labs,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Elevai Labs,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Elevai Labs,'s management manipulating its earnings.
Basic technical analysis of Elevai Stock
As of the 2nd of March, Elevai Labs, shows the Variance of 119.87, standard deviation of 10.95, and Mean Deviation of 6.38. Elevai Labs, Common technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Elevai Labs,'s insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elevai Labs, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elevai Labs,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elevai Labs, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Gransee David H over three weeks ago Acquisition by Gransee David H of 4800 shares of Elevai Labs, at 1.05 subject to Rule 16b-3 | ||
Braeden Lichti over a year ago Elevai Labs exotic insider transaction detected | ||
Beuchler Brenda over a year ago Elevai Labs exotic insider transaction detected | ||
Jp Bio Consulting Llc over a year ago Elevai Labs exotic insider transaction detected |
Understand Elevai Labs,'s technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Elevai Labs,'s various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 1.27 | |||
| Mean Deviation | 6.38 | |||
| Coefficient Of Variation | (921.58) | |||
| Standard Deviation | 10.95 | |||
| Variance | 119.87 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (1.22) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | 1.26 | |||
| Maximum Drawdown | 90.44 | |||
| Value At Risk | (18.75) | |||
| Potential Upside | 9.3 | |||
| Skewness | 1.79 | |||
| Kurtosis | 12.31 |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 1.27 | |||
| Mean Deviation | 6.38 | |||
| Coefficient Of Variation | (921.58) | |||
| Standard Deviation | 10.95 | |||
| Variance | 119.87 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (1.22) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | 1.26 | |||
| Maximum Drawdown | 90.44 | |||
| Value At Risk | (18.75) | |||
| Potential Upside | 9.3 | |||
| Skewness | 1.79 | |||
| Kurtosis | 12.31 |
Consider Elevai Labs,'s intraday indicators
Elevai Labs, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Elevai Labs, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Elevai Labs, time-series forecasting models is one of many Elevai Labs,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Elevai Labs,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Elevai Stock media impact
Far too much social signal, news, headlines, and media speculation about Elevai Labs, that are available to investors today. That information is available publicly through Elevai media outlets and privately through word of mouth or via Elevai internal channels. However, regardless of the origin, that massive amount of Elevai data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Elevai Labs, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Elevai Labs, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Elevai Labs,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Elevai Labs, alpha.
Elevai Labs, Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Elevai Labs, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Elevai Labs, Common Historical Investor Sentiment
Investor biases related to Elevai Labs,'s public news can be used to forecast risks associated with an investment in Elevai. The trend in average sentiment can be used to explain how an investor holding Elevai can time the market purely based on public headlines and social activities around Elevai Labs, Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Elevai Labs,'s market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Elevai Labs, and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Elevai Labs, news discussions. The higher the estimate score, the more favorable the investor's outlook on Elevai Labs,.
Elevai Labs, Corporate Executives
Elected by the shareholders, the Elevai Labs,'s board of directors comprises two types of representatives: Elevai Labs, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elevai. The board's role is to monitor Elevai Labs,'s management team and ensure that shareholders' interests are well served. Elevai Labs,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elevai Labs,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| FACS FACS | Chief CoFounder | Profile | |
| Graydon CFA | Secretary CFO | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevai Labs, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs,. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (88.92) | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets | Return On Equity |
The market value of Elevai Labs, Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs,'s value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs,'s market value can be influenced by many factors that don't directly affect Elevai Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Elevai Labs,'s value and its price, as these two are different measures arrived at by various means. Investors typically determine if Elevai Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.